Learn More
Medchemexpress LLC Farnesyl pyrophosphate ammonium | 116057-57-9 | 95.39% | 433.42 | 1 MG

Supplier: Medchemexpress LLC HY113037C1MG
Farnesyl pyrophosphate ammonium is a metabolic intermediate in the mevalonate (MVA) pathway. It acts as a TRP channel (TRPM2) agonist, triggering Ca2+ influx and cell death. It is a crucial branch substrate for various biological syntheses and is utilized in research concerning a range of diseases.
- Acts as a TRP channel (TRPM2) agonist
- Triggers Ca2+ influx and cell death
- Key branch substrate for cholesterol synthesis
- Key branch substrate for ubiquinone synthesis
- Key branch substrate for protein farnesylation
- Key branch substrate for geranylgeranyl pyrophosphate (GGPP) synthesis
- Used in research on cerebral ischemia
- Used in research on neurodegenerative diseases
- Used in research on pancreatic cancer
- Used in research on inflammation
- Used in research on autoimmune diseases
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.